论文部分内容阅读
剖宫产产后出血是分娩常见的并发症。目前,临床常采用缩宫素、米索前列醇等药物促使子宫收缩,改善宫缩乏力症状,但部分产妇产后使用缩宫素后,宫缩效果不佳需增加用药剂量,易诱发多种不良用药反应。因此,临床需探讨更高效、安全的药物,预防产后出血。本文观察了对产后出血高危产妇采用缩宫素联合卡前列素氨丁三醇注射液预防剖宫产产后出血的效果。
Cesarean section postpartum hemorrhage is a common complication of labor. At present, the clinical often use oxytocin, misoprostol and other drugs to promote uterine contraction and improve the symptoms of uterine atony, but some of the postpartum use of oxytocin, uterine contractions ineffective to increase the dosage, easy to induce a variety of adverse Medication reaction. Therefore, the clinical need to explore more efficient and safe drugs to prevent postpartum hemorrhage. This article observed the use of oxytocin combined with carboprost tromethamine in preventing postpartum hemorrhage high-risk mothers bleeding after cesarean section.